Clinical Trials Browser

Prostatic Neoplasms

Pathological and Imaging Examinations Confirmed Metastatic Prostate Cancer

Prostatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Head and Neck Neoplasms

Breast Neoplasm Female

Breast Neoplasms

Esophageal Neoplasms, Drug-Related Side Effects and Adverse Reactions

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Infections, Thrombosis

Peritoneal Neoplasms, Stomach Neoplasms

Adenocarcinoma

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Breast Diseases, Breast Neoplasms

Breast Neoplasms, Breast Neoplasms, Male

Breast Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Breast Neoplasms

Breast Neoplasms

Amenorrhea, Breast Neoplasms

Uterine Neoplasms

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinogenesis

Hormone Refractory Prostate Cancer

Pancreatic Neoplasms

Breast Neoplasms, Breast Neoplasms, Male

Breast Neoplasms

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Clinical Trials

LUNG-05

Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC

Clinical Study of Rezvilutamide Combined With Docetaxel Chemotherapy in the Treatment of Abiraterone-Resistant Prostate Cancer

PKUFH-GS5

Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer

ASOG-HNO1

neoPICD

Evaluating Xihuang Pill to Improve the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer

Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer

easy laugh

SLAT

Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study

PICC&PAC

GASPACCO

Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer

TC Avastin. ICORG 08-10, V6

PBIC

mEGA

Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer

A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer

Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients

Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus

Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer

Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

Molecular Phenotype Changes and Personalized Treatment for CRPC

Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.

Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer

Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer

Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer

IST 16167